These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 12548064

  • 1. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children.
    Madrazo-de la Garza A, Dibildox M, Vargas A, Delgado J, Gonzalez J, Yañez P.
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):261-5. PubMed ID: 12548064
    [Abstract] [Full Text] [Related]

  • 2. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Feb; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 3. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL, Houcke P, Samoyeau R, French Collaborative Pantaprazole Study Group.
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
    Wurzer H, Schutze K, Bethke T, Fischer R, Luhmann R, Riesenhuber C.
    Hepatogastroenterology; 1999 Mar; 46(27):1809-15. PubMed ID: 10430350
    [Abstract] [Full Text] [Related]

  • 5. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.
    Digestion; 2003 Mar; 67(1-2):6-13. PubMed ID: 12743434
    [Abstract] [Full Text] [Related]

  • 6. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE, Bochenek W.
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [Abstract] [Full Text] [Related]

  • 7. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis.
    Bardhan KD, Van Rensburg C.
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998
    [Abstract] [Full Text] [Related]

  • 8. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A, Vogt R, Sielaff F, Lühmann R, Schneider A, Fischer R.
    Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
    [Abstract] [Full Text] [Related]

  • 9. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A, Stimac D, Vceva A, Takac B, Ivandić A, Pezerović D, Horvat D, Nedić P, Kotromanović Z, Maksimović Z, Vranjes Z, Males J, Jurisić-Orzen D, Vladika I, Stimac T, Mandić B.
    Acta Med Croatica; 1999 Sep; 53(2):79-82. PubMed ID: 10705625
    [Abstract] [Full Text] [Related]

  • 10. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 11. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G, Cain C, Malfertheiner P.
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.
    Van Rensburg CJ, Honiball PJ, Van Zyl JH, Grundling HD, Eloff FP, Spies SK, Simjee AE, Theron I, Fischer R, Louw JA.
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1023-8. PubMed ID: 10468676
    [Abstract] [Full Text] [Related]

  • 13. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J, Koop H, Porst H, Wübbolding H, Schneider A, Maier C.
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
    [Abstract] [Full Text] [Related]

  • 14. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
    Corinaldesi R, Valentini M, Belaïche J, Colin R, Geldof H, Maier C.
    Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J, van Rensburg C, Vieweg W, Fischer R.
    Digestion; 2004 Dec; 70(1):61-9. PubMed ID: 15297779
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
    Meneghelli UG, Boaventura S, Moraes-Filho JP, Leitão O, Ferrari AP, Almeida JR, Magalhães AF, Castro LP, Haddad MT, Tolentino M, Jorge JL, Silva E, Maguilnik I, Fischer R.
    Dis Esophagus; 2002 Dec; 15(1):50-6. PubMed ID: 12060043
    [Abstract] [Full Text] [Related]

  • 17. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.
    Pratha V, Hogan DL, Lynn RB, Field B, Metz DC.
    Dig Dis Sci; 2006 Sep; 51(9):1595-601. PubMed ID: 16927137
    [Abstract] [Full Text] [Related]

  • 18. Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis.
    Moretzsohn LD, Brito EM, Reis MS, Coelho LG, Castro Lde P.
    Arq Gastroenterol; 2002 Sep; 39(2):123-5. PubMed ID: 12612717
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
    van Rensburg CJ, Honiball PJ, Grundling HD, van Zyl JH, Spies SK, Eloff FP, Simjee AE, Segal I, Botha JF, Cariem AK, Marks IN, Theron I, Bethke TD.
    Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.